248 related articles for article (PubMed ID: 1348570)
1. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation.
Xi YG; Ingrosso L; Ladogana A; Masullo C; Pocchiari M
Nature; 1992 Apr; 356(6370):598-601. PubMed ID: 1348570
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie.
Demaimay R; Adjou K; Lasmézas C; Lazarini F; Cherifi K; Seman M; Deslys JP; Dormont D
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2499-503. PubMed ID: 7915757
[TBL] [Abstract][Full Text] [Related]
3. Immunoaffinity purification and neutralization of scrapie prions.
Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
[TBL] [Abstract][Full Text] [Related]
4. Spongiform encephalopathies. PrP and the scrapie agent.
Chesebro B
Nature; 1992 Apr; 356(6370):560. PubMed ID: 1348569
[No Abstract] [Full Text] [Related]
5. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection.
McKenzie D; Kaczkowski J; Marsh R; Aiken J
J Virol; 1994 Nov; 68(11):7534-6. PubMed ID: 7933137
[TBL] [Abstract][Full Text] [Related]
7. MS-8209, an amphotericin B analogue, delays the appearance of spongiosis, astrogliosis and PrPres accumulation in the brain of scrapie-infected hamsters.
Adjou KT; Privat N; Demart S; Deslys JP; Seman M; Hauw JJ; Dormont D
J Comp Pathol; 2000 Jan; 122(1):3-8. PubMed ID: 10627386
[TBL] [Abstract][Full Text] [Related]
8. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
9. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
10. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
11. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
12. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
13. Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins.
Rubenstein R; Merz PA; Kascsak RJ; Scalici CL; Papini MC; Carp RI; Kimberlin RH
J Infect Dis; 1991 Jul; 164(1):29-35. PubMed ID: 1676044
[TBL] [Abstract][Full Text] [Related]
14. Introduction to scrapie and perspectives on current scrapie research.
Kimberlin RH
Prog Clin Biol Res; 1989; 317():559-66. PubMed ID: 2574870
[TBL] [Abstract][Full Text] [Related]
15. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells.
Priola SA; Caughey B; Raymond GJ; Chesebro B
Infect Agents Dis; 1994; 3(2-3):54-8. PubMed ID: 7812655
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sinc genotype, agent isolate and route of infection on the accumulation of protease-resistant PrP in non-central nervous system tissues during the development of murine scrapie.
Farquhar CF; Dornan J; Somerville RA; Tunstall AM; Hope J
J Gen Virol; 1994 Mar; 75 ( Pt 3)():495-504. PubMed ID: 7907357
[TBL] [Abstract][Full Text] [Related]
17. Normal host prion protein necessary for scrapie-induced neurotoxicity.
Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
[TBL] [Abstract][Full Text] [Related]
18. Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
Jeffrey M; Goodsir CM; Race RE; Chesebro B
Ann Neurol; 2004 Jun; 55(6):781-92. PubMed ID: 15174012
[TBL] [Abstract][Full Text] [Related]
19. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
20. Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters.
Adjou KT; Dilda P; Aumond P; Gueddari S; Deslys JP; Dormont D; Seman M
Neurochem Int; 2008 Jun; 52(8):1416-21. PubMed ID: 18442871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
